News und Analysen
Poxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
EQS-News: Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
Voyageurs du Monde: Profits up in 2022 and sharp increase in bookings for 2023
GEVELOT S.A.: Weekly report of share buyback February 7, 2023
ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
GEVELOT S.A.: Weekly report of share buyback January 30 01 2023
Verimatrix Secure Delivery Plattform feiert ihr erstes Jahr mit Milliarden von Lizenzen für die Videoübertragung
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass seineVerimatrix Secure Delivery Plattform in weniger als
Verimatrix Secure Delivery Platform Marks Its First Year with Billions of Video Viewership Licenses Served
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced its Verimatrix Secure Delivery
Axway Software: Upward Revision of 2022 Annual Targets
Regulatory News:
Axway (Paris:AXW) today announces an upward revision of its organic growth and profitability guidance for the fiscal year ended December 31, 2022. While the company will present
Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
GEVELOT S.A.: Weekly report of share buyback January 20 01 2023
Die ESI Group bekräftigt ihr Engagement für die Gleichstellung von Mann und Frau am Arbeitsplatz und unterzeichnet die Women’s Empowerment Principles der Vereinten Nationen zur Stärkung von Frauen in Unternehmen
Die ESI Group (ISIN-Code: FR0004110310, Symbol: ESI), ein weltweit operierender Softwarepartner der Industrie für Simulation und virtuelles Prototyping, hat die Women's Empowerment Principles (WEP)
ESI Group Reinforces Its Commitment to Gender Equality at Work and Signs the United Nations Women's Empowerment Principles
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), a global simulation and virtual prototyping software partner for the industry, has signed the United Nations Women's Empowerment
Danone-Gruppe beauftragt BALYO mit der Automatisierung eines ihrer Werke mit einer Flotte autonomer «REACHY»-Schubmaststapler
BALYO (FR0013258399, Tickersymbol: BALYO, PEA-PME-qualifiziert), Technologieführer im Bereich Konzeption und Entwicklung innovativer Roboterlösungen für Flurförderzeuge, gibt bekannt, von der
GEVELOT S.A.: Weekly report of share buyback January 12, 2023
Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions
Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces it has received
GEVELOT S.A.: Weekly report of share buyback January 5, 2023
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
EQS-News: Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action
Swisscom erweitert das Vertrauen in Verimatrix VCAS mit vollständiger Migration in die Cloud
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt teilte heute mit, dass Swisscom, ein langjähriger Kunde von
Poxel Announces Upcoming Participation at Investor Conferences
POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Swisscom Expands Trust in Verimatrix VCAS with Full Migration to the Cloud
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Swisscom, a longstanding Verimatrix
Transgene Announces Financial Calendar for 2023
Regulatory News:
TRANSGENE (Paris: TNG) today announced its financial reporting dates for 2023:
March 16, 2023:
2022 Fiscal Year Results
May 10, 2023:
First